Savara Inc
SVRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001160308
No open-market purchases or sales by Savara Inc insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.
Holders of 5% or more of SVRA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Savara Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Growth Equity Opportunities 17, LLC | 13D/A | 12.00%24.5M shares | – | Mar 25, 20212 filings | Nov 14, 2025 | SEC |
| Bain Capital Life Sciences Fund II, L.P. | 13D/A | 9.99%17.6M shares | – | Mar 17, 20212 filings | Mar 27, 2025 | SEC |
| Venrock Healthcare Capital Partners III, L.P. | 13G/A | 9.90%20.9M shares | +2.60 ppfrom 7.30% | Jul 8, 20253 filings | Feb 17, 2026 | SEC |
| Farallon Capital Partners, L.P. | 13G/A | 6.90%15.0M shares | −3.09 ppfrom 9.99% | Feb 11, 20252 filings | Feb 5, 2026 | SEC |
| Flynn James E | 13G | 6.74%13.6M shares | New | Nov 5, 20251 filing | Nov 5, 2025 | SEC |
| TCG Crossover GP I, LLC | 13G/A | 6.10%12.4M shares | – | Feb 17, 20261 filing | Feb 17, 2026 | SEC |
| BlackRock, Inc. | 13G | 5.40%11.0M shares | +0.60 ppfrom 4.80% | Oct 17, 20252 filings | Jan 21, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
31 Schedule 13D and 13G filings on Savara Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 20266:18 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G/A | 9.90%20.9M shares | +2.60 ppfrom 7.30% | Dec 31, 2025 | SEC |
| Feb 17, 20264:27 PM ET | TCG Crossover GP I, LLCand 2 others | 13G/A | 6.10%12.4M shares | – | Dec 31, 2025 | SEC |
| Feb 13, 20265:30 PM ET | Frazier Life Sciences Public Fund, L.P.and 10 others | 13G/A | 4.10%8.34M shares | +0.20 ppfrom 3.90%Below 5% | Dec 31, 2025 | SEC |
| Feb 13, 20265:06 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 3.61%7.34M shares | −1.47 ppfrom 5.08%Below 5% | Dec 31, 2025 | SEC |
| Feb 5, 20262:54 PM ET | Farallon Capital Partners, L.P.and 28 others | 13G/A | 6.90%15.0M shares | −3.09 ppfrom 9.99% | Dec 31, 2025 | SEC |
| Jan 21, 202612:30 PM ET | BlackRock, Inc. | 13G | 5.40%11.0M shares | +0.60 ppfrom 4.80% | Dec 31, 2025 | SEC |
| Nov 14, 20255:37 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G/A | 7.30%12.7M shares | +2.10 ppfrom 5.20% | Sep 30, 2025 | SEC |
| Nov 14, 20254:33 PM ET | Nantahala Capital Management, LLCand 2 others | 13G | 5.08%8.78M shares | New | Sep 30, 2025 | SEC |
| Nov 14, 20254:27 PM ET | Growth Equity Opportunities 17, LLCand 12 others | 13D/A | 12.00%24.5M shares | – | Nov 12, 2025 | SEC |
| Nov 14, 20254:04 PM ET | Vestal Point Capital, LPand 1 other | 13G/A | 2.30%4.01M shares | −4.00 ppfrom 6.30%Below 5% | Sep 30, 2025 | SEC |
| Nov 5, 20256:24 PM ET | Flynn James Eand 3 others | 13G | 6.74%13.6M shares | New | Oct 30, 2025 | SEC |
| Oct 17, 20256:41 PM ET | BlackRock, Inc. | 13G/A | 4.80%8.31M shares | –Below 5% | Sep 30, 2025 | SEC |
| Aug 14, 20251:12 PM ET | Frazier Life Sciences Public Fund, L.P.and 16 others | 13G/A | 3.90%6.75M shares | −2.70 ppfrom 6.60%Below 5% | Jun 30, 2025 | SEC |
| Jul 8, 20255:31 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G | 5.20%9.02M shares | New | Jun 30, 2025 | SEC |
| May 15, 20259:52 AM ET | Frazier Life Sciences Public Fund, L.P.and 16 others | 13G/A | 6.60%11.5M shares | – | Mar 31, 2025 | SEC |
| Mar 27, 20255:40 PM ET | Bain Capital Life Sciences Fund II, L.P.and 2 others | 13D/A | 9.99%17.6M shares | – | Mar 25, 2025 | SEC |
| Feb 14, 20252:33 PM ET | Vestal Point Capital, LPand 1 other | 13G | 6.30%10.8M shares | New | Dec 31, 2024 | SEC |
| Feb 11, 20255:14 PM ET | Farallon Capital Partners, L.P.and 27 others | 13G/A | 9.99%18.3M shares | – | Dec 31, 2024 | SEC |
| Feb 10, 202510:25 AM ET | Wellington Management Group LLPand 2 others | 13G/A | 3.20%5.48M shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 2023 | Venrock Healthcare Capital Partners II, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | EcoR1 Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Caxton Corp | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Adage Capital Partners GP, L.L.C. | 13G/AOld format | – | – | – | SEC |
| Apr 9, 20216:02 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Mar 25, 2021 | Growth Equity Opportunities 17, LLC | 13DOld format | – | New | – | SEC |
| Mar 25, 2021 | Adage Capital Partners GP, L.L.C. | 13GOld format | – | New | – | SEC |
| Mar 19, 2021 | Caxton Corp | 13GOld format | – | New | – | SEC |
| Mar 17, 2021 | Bain Capital Life Sciences Fund II, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 16, 2021 | EcoR1 Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | EcoR1 Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 2, 20213:13 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Savara Inc shares.
No Form 144 notices for Savara Inc are on file.